Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA note clarifying that PubMed publications are automatically filled and may not be about the study; revision: v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding notice was removed from the page. It does not affect the study details, eligibility criteria, or participation instructions.SummaryDifference0.3%

- Check33 days agoChange DetectedStudy Details page for NCT02657889 shows no significant changes between screenshots; core information about the TOPACIO trial appears unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedUpdated version to v3.2.0 and added a government-operation status notice; removed the v3.1.0 reference.SummaryDifference2%

- Check69 days agoChange DetectedAdded v3.1.0 and removed the Ovarian cancer resource; older v3.0.2 revision reference was present. Overall, versioning and resource scope changed.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top link was removed; this is a minor UI change with no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.